ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Market Research Report 2026
Published Date: 2026-01-07
|
Report Code: QYRE-Auto-2H20365
Home | Market Reports | Health| Nutrition| Vitamins & Supplements
Global Raw Materials for Longevity Drug NMN Nicotinamide Mononucleotide Market Research Report 2026
BUY CHAPTERS

Global Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Market Research Report 2026

Code: QYRE-Auto-2H20365
Report
2026-01-07
Pages:138
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Herbalmax
Genex Formulas
Maac10 Formulas
GeneHarbor
Bontac
CELFULL
Zhongsheng Pharmaceutical
Mirailab Bioscience
EffePharm
Kingdomway
Yaben Chemical

Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Market Size

The global Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) market was valued at US$ 512 million in 2025 and is anticipated to reach US$ 1203 million by 2032, at a CAGR of 13.0% from 2026 to 2032.

Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Market

Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
In 2024, global Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) production reached approximately 1700 tons, with an average global market price of around US$300,000 per ton. In 2024, the global 's total production capacity of Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) reached 2100 tons. The industry average gross profit margin of this product reached 36%.Nicotinamide mononucleotide (NMN) is a naturally occurring bioactive nucleotide and one of the most direct precursors to nicotinamide adenine dinucleotide (NAD+), an important coenzyme in the human body. Its molecule consists of a nicotinamide group, ribose, and a phosphate group. With age, NAD+ levels in the body decline significantly, which is considered closely related to various age-related functional declines. Theoretically, NMN supplementation can be efficiently absorbed by cells and rapidly converted into NAD+, thereby activating the Sirtuins longevity protein family, which depends on NAD+ for function. Sirtuins play a central role in key physiological processes such as mitochondrial function, DNA repair, cellular energy metabolism, and circadian rhythm regulation. Therefore, it has been extensively researched and commercialized, serving as one of the most representative dietary supplement ingredients in the current anti-aging and metabolic health field.
The nicotinamide mononucleotide (NMN) industry chain has formed a complete chain from research and development to end-consumer. Upstream mainly consists of basic chemical raw material suppliers and specialized technical research institutions, focusing on breakthroughs and optimization of synthesis processes. The midstream is the core production stage, dominated by large biotechnology companies and chemical plants. Through chemical synthesis or enzymatic methods, they conduct large-scale production of NMN raw material powders of varying purities, which are then processed into various dosage forms. The downstream is divided into B2B and B2C markets: B2B includes health supplement brands, cosmetics companies, and research institutions, which process the raw materials into end products or use them for research; B2C reaches global consumers through cross-border e-commerce, online platforms, and offline channels. Strict quality and regulatory oversight permeates the entire industry chain, serving as both a key constraint and driving force for its development.
The market prospects for nicotinamide mononucleotide (NMN) are broad but face key challenges. In the short term, as a dietary supplement, its market size continues to expand driven by global aging and health-conscious consumption trends. Advances in production technology will lead to cost reductions and increased market penetration. Medium-term development heavily relies on breakthroughs in clinical research: results from ongoing human clinical trials, if providing solid evidence regarding its safety and efficacy, will greatly enhance consumer confidence and potentially lead to regulatory easing, such as granting it legal health food status in the Chinese market. In the long term, NMN's development faces two possible paths: First, if clinical evidence is conclusive, it may be upgraded to a prescription drug or medical food for adjuvant treatment of specific diseases, leading to a reassessment of its value. Second, if the primary market remains as a supplement, competition will intensify, requiring brands to build barriers through formula innovation, dosage form optimization, and in-depth functional segmentation. Simultaneously, its application in high-end functional skincare products is also a significant growth driver. Overall, the future of NMN will be shaped by the combined forces of science, regulation, and the market.
The North American market for Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) include Herbalmax, Genex Formulas, Maac10 Formulas, GeneHarbor, Bontac, CELFULL, Zhongsheng Pharmaceutical, Mirailab Bioscience, EffePharm, Kingdomway, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide). The Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) market size, estimates, and forecasts are provided in terms of shipments (Tons) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) market comprehensively. Regional market sizes by Type, by Application, by Manufacturing Process, and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) manufacturers, new entrants, and companies across the industry value chain with information on revenues, production, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Market Report

Report Metric Details
Report Name Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Market
Accounted market size in 2025 US$ 512 million
Forecasted market size in 2032 US$ 1203 million
CAGR 13.0%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • Purity ≥98%
  • Purity <98%
Segment by Manufacturing Process
  • Chemical Synthesis
  • Enzyme Catalysis
  • Fermentation
by Application
  • Pharmaceuticals
  • Health Products
  • Others
Production by Region
  • North America
  • Europe
  • China
  • Japan
  • India
  • Southeast Asia
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Herbalmax, Genex Formulas, Maac10 Formulas, GeneHarbor, Bontac, CELFULL, Zhongsheng Pharmaceutical, Mirailab Bioscience, EffePharm, Kingdomway, ‌Yaben Chemical‌
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Manufacturing Process, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) manufacturers, including prices, production, value-based market shares, latest development plans, and information on mergers and acquisitions.
  • Chapter 3: Examines Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) production/output and value by region and country, providing a quantitative assessment of market size and growth potential for each region over the next six years.
  • Chapter 4: Analyzes Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) consumption at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national production.
  • Chapter 5: Analyzes market segments by Type, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 6: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 7: Profiles key players, detailing the fundamentals of major companies, including product production/output, value, price, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 8: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 9: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 10: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Market growing?

Ans: The Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Market witnessing a CAGR of 13.0% during the forecast period 2026-2032.

What is the Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Market size in 2032?

Ans: The Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Market size in 2032 will be US$ 1203 million.

Who are the main players in the Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Market report?

Ans: The main players in the Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Market are Herbalmax, Genex Formulas, Maac10 Formulas, GeneHarbor, Bontac, CELFULL, Zhongsheng Pharmaceutical, Mirailab Bioscience, EffePharm, Kingdomway, ‌Yaben Chemical‌

What are the Application segmentation covered in the Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Market report?

Ans: The Applications covered in the Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Market report are Pharmaceuticals, Health Products, Others

What are the Type segmentation covered in the Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Market report?

Ans: The Types covered in the Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Market report are Purity ≥98%, Purity <98%

1 Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Market Overview
1.1 Product Definition
1.2 Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) by Type
1.2.1 Global Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Market Value Growth Rate Analysis by Type: 2025 vs 2032
1.2.2 Purity ≥98%
1.2.3 Purity <98%
1.3 Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) by Manufacturing Process
1.3.1 Global Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Market Value Growth Rate Analysis by Manufacturing Process: 2025 vs 2032
1.3.2 Chemical Synthesis
1.3.3 Enzyme Catalysis
1.3.4 Fermentation
1.4 Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) by Application
1.4.1 Global Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Market Value Growth Rate Analysis by Application: 2025 vs 2032
1.4.2 Pharmaceuticals
1.4.3 Health Products
1.4.4 Others
1.5 Global Market Growth Prospects
1.5.1 Global Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Value Estimates and Forecasts (2021–2032)
1.5.2 Global Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Capacity Estimates and Forecasts (2021–2032)
1.5.3 Global Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Estimates and Forecasts (2021–2032)
1.5.4 Global Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Market Average Price Estimates and Forecasts (2021–2032)
1.6 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Market Share by Manufacturers (2021–2026)
2.2 Global Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Value Market Share by Manufacturers (2021–2026)
2.3 Global Key Players of Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide), Industry Ranking, 2024 vs 2025
2.4 Global Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.5 Global Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Average Price by Manufacturers (2021–2026)
2.6 Global Key Manufacturers of Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide), Manufacturing Footprints and Headquarters
2.7 Global Key Manufacturers of Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide), Product Offerings and Applications
2.8 Global Key Manufacturers of Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide), Date of Entry into the Industry
2.9 Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Market Competitive Situation and Trends
2.9.1 Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Market Concentration Rate
2.9.2 Top 5 and Top 10 Global Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Players Market Share by Revenue
2.10 Mergers & Acquisitions and Expansion
3 Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production by Region
3.1 Global Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Value Estimates and Forecasts by Region: 2021 vs 2025 vs 2032
3.2 Global Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Value by Region (2021–2032)
3.2.1 Global Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Value by Region (2021–2026)
3.2.2 Global Forecasted Production Value of Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) by Region (2027–2032)
3.3 Global Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Estimates and Forecasts by Region: 2021 vs 2025 vs 2032
3.4 Global Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Volume by Region (2021–2032)
3.4.1 Global Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production by Region (2021–2026)
3.4.2 Global Forecasted Production of Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) by Region (2027–2032)
3.5 Global Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Market Price Analysis by Region (2021–2026)
3.6 Global Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production, Value, and Year-over-Year Growth
3.6.1 North America Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Value Estimates and Forecasts (2021–2032)
3.6.2 Europe Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Value Estimates and Forecasts (2021–2032)
3.6.3 China Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Value Estimates and Forecasts (2021–2032)
3.6.4 Japan Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Value Estimates and Forecasts (2021–2032)
3.6.5 India Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Value Estimates and Forecasts (2021–2032)
3.6.6 Southeast Asia Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Value Estimates and Forecasts (2021–2032)
4 Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Consumption by Region
4.1 Global Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Consumption Estimates and Forecasts by Region: 2021 vs 2025 vs 2032
4.2 Global Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Consumption by Region (2021–2032)
4.2.1 Global Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Consumption by Region (2021–2026)
4.2.2 Global Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Forecasted Consumption by Region (2027–2032)
4.3 North America
4.3.1 North America Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Consumption Growth Rate by Country: 2021 vs 2025 vs 2032
4.3.2 North America Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Consumption by Country (2021–2032)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Consumption Growth Rate by Country: 2021 vs 2025 vs 2032
4.4.2 Europe Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Consumption by Country (2021–2032)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Consumption Growth Rate by Region: 2021 vs 2025 vs 2032
4.5.2 Asia Pacific Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Consumption by Region (2021–2032)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Consumption Growth Rate by Country: 2021 vs 2025 vs 2032
4.6.2 Latin America, Middle East & Africa Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Consumption by Country (2021–2032)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
4.6.6 GCC Countries
5 Segment by Type
5.1 Global Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production by Type (2021–2032)
5.1.1 Global Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production by Type (2021–2026)
5.1.2 Global Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production by Type (2027–2032)
5.1.3 Global Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Market Share by Type (2021–2032)
5.2 Global Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Value by Type (2021–2032)
5.2.1 Global Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Value by Type (2021–2026)
5.2.2 Global Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Value by Type (2027–2032)
5.2.3 Global Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Value Market Share by Type (2021–2032)
5.3 Global Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Price by Type (2021–2032)
6 Segment by Application
6.1 Global Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production by Application (2021–2032)
6.1.1 Global Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production by Application (2021–2026)
6.1.2 Global Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production by Application (2027–2032)
6.1.3 Global Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Market Share by Application (2021–2032)
6.2 Global Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Value by Application (2021–2032)
6.2.1 Global Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Value by Application (2021–2026)
6.2.2 Global Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Value by Application (2027–2032)
6.2.3 Global Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Value Market Share by Application (2021–2032)
6.3 Global Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Price by Application (2021–2032)
7 Key Companies Profiled
7.1 Herbalmax
7.1.1 Herbalmax Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Company Information
7.1.2 Herbalmax Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Product Portfolio
7.1.3 Herbalmax Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production, Value, Price, and Gross Margin (2021–2026)
7.1.4 Herbalmax Main Business and Markets Served
7.1.5 Herbalmax Recent Developments/Updates
7.2 Genex Formulas
7.2.1 Genex Formulas Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Company Information
7.2.2 Genex Formulas Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Product Portfolio
7.2.3 Genex Formulas Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production, Value, Price, and Gross Margin (2021–2026)
7.2.4 Genex Formulas Main Business and Markets Served
7.2.5 Genex Formulas Recent Developments/Updates
7.3 Maac10 Formulas
7.3.1 Maac10 Formulas Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Company Information
7.3.2 Maac10 Formulas Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Product Portfolio
7.3.3 Maac10 Formulas Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production, Value, Price, and Gross Margin (2021–2026)
7.3.4 Maac10 Formulas Main Business and Markets Served
7.3.5 Maac10 Formulas Recent Developments/Updates
7.4 GeneHarbor
7.4.1 GeneHarbor Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Company Information
7.4.2 GeneHarbor Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Product Portfolio
7.4.3 GeneHarbor Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production, Value, Price, and Gross Margin (2021–2026)
7.4.4 GeneHarbor Main Business and Markets Served
7.4.5 GeneHarbor Recent Developments/Updates
7.5 Bontac
7.5.1 Bontac Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Company Information
7.5.2 Bontac Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Product Portfolio
7.5.3 Bontac Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production, Value, Price, and Gross Margin (2021–2026)
7.5.4 Bontac Main Business and Markets Served
7.5.5 Bontac Recent Developments/Updates
7.6 CELFULL
7.6.1 CELFULL Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Company Information
7.6.2 CELFULL Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Product Portfolio
7.6.3 CELFULL Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production, Value, Price, and Gross Margin (2021–2026)
7.6.4 CELFULL Main Business and Markets Served
7.6.5 CELFULL Recent Developments/Updates
7.7 Zhongsheng Pharmaceutical
7.7.1 Zhongsheng Pharmaceutical Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Company Information
7.7.2 Zhongsheng Pharmaceutical Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Product Portfolio
7.7.3 Zhongsheng Pharmaceutical Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production, Value, Price, and Gross Margin (2021–2026)
7.7.4 Zhongsheng Pharmaceutical Main Business and Markets Served
7.7.5 Zhongsheng Pharmaceutical Recent Developments/Updates
7.8 Mirailab Bioscience
7.8.1 Mirailab Bioscience Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Company Information
7.8.2 Mirailab Bioscience Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Product Portfolio
7.8.3 Mirailab Bioscience Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production, Value, Price, and Gross Margin (2021–2026)
7.8.4 Mirailab Bioscience Main Business and Markets Served
7.8.5 Mirailab Bioscience Recent Developments/Updates
7.9 EffePharm
7.9.1 EffePharm Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Company Information
7.9.2 EffePharm Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Product Portfolio
7.9.3 EffePharm Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production, Value, Price, and Gross Margin (2021–2026)
7.9.4 EffePharm Main Business and Markets Served
7.9.5 EffePharm Recent Developments/Updates
7.10 Kingdomway
7.10.1 Kingdomway Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Company Information
7.10.2 Kingdomway Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Product Portfolio
7.10.3 Kingdomway Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production, Value, Price, and Gross Margin (2021–2026)
7.10.4 Kingdomway Main Business and Markets Served
7.10.5 Kingdomway Recent Developments/Updates
7.11 ‌Yaben Chemical‌
7.11.1 ‌Yaben Chemical‌ Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Company Information
7.11.2 ‌Yaben Chemical‌ Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Product Portfolio
7.11.3 ‌Yaben Chemical‌ Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production, Value, Price, and Gross Margin (2021–2026)
7.11.4 ‌Yaben Chemical‌ Main Business and Markets Served
7.11.5 ‌Yaben Chemical‌ Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Industry Chain Analysis
8.2 Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Raw Material Supply Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Modes and Processes
8.4 Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Sales and Marketing
8.4.1 Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Sales Channels
8.4.2 Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Distributors
8.5 Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Customer Analysis
9 Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Market Dynamics
9.1 Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Industry Trends
9.2 Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Market Drivers
9.3 Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Market Challenges
9.4 Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Market Restraints
9.5 Impact of U.S. Tariffs
10 Research Findings and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
FEATURED COMPANIES
Herbalmax
Genex Formulas
Maac10 Formulas
GeneHarbor
Bontac
CELFULL
Zhongsheng Pharmaceutical
Mirailab Bioscience
EffePharm
Kingdomway
Yaben Chemical
List of Tables
 Table 1. Global Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Market Value by Manufacturing Process (US$ Million), 2025 vs 2032
 Table 3. Global Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Market Value by Application (US$ Million), 2025 vs 2032
 Table 4. Global Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Capacity (Tons) by Manufacturers in 2025
 Table 5. Global Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production by Manufacturers (Tons), 2021–2026
 Table 6. Global Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Market Share by Manufacturers (2021–2026)
 Table 7. Global Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Value by Manufacturers (US$ Million), 2021–2026
 Table 8. Global Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Value Share by Manufacturers (2021–2026)
 Table 9. Global Key Players of Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide), Industry Ranking, 2024 vs 2025
 Table 10. Classification of Companies by Tier (Tier 1, Tier 2, Tier 3), based on Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Value, 2025
 Table 11. Global Market Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Average Price by Manufacturers (US$/Ton), 2021–2026
 Table 12. Global Key Manufacturers of Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide), Manufacturing Footprints and Headquarters
 Table 13. Global Key Manufacturers of Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide), Product Offerings and Applications
 Table 14. Global Key Manufacturers of Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide), Date of Entry into the Industry
 Table 15. Global Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 16. Mergers & Acquisitions and Expansion Plans
 Table 17. Global Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Value by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 18. Global Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Value (US$ Million) by Region (2021–2026)
 Table 19. Global Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Value Market Share by Region (2021–2026)
 Table 20. Global Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Value (US$ Million) Forecast by Region (2027–2032)
 Table 21. Global Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Value Market Share Forecast by Region (2027–2032)
 Table 22. Global Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Comparison by Region: 2021 vs 2025 vs 2032 (Tons)
 Table 23. Global Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production (Tons) by Region (2021–2026)
 Table 24. Global Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Market Share by Region (2021–2026)
 Table 25. Global Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production (Tons) Forecast by Region (2027–2032)
 Table 26. Global Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Market Share Forecast by Region (2027–2032)
 Table 27. Global Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Market Average Price (US$/Ton) by Region (2021–2026)
 Table 28. Global Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Market Average Price (US$/Ton) by Region (2027–2032)
 Table 29. Global Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Consumption Growth Rate by Region: 2021 vs 2025 vs 2032 (Tons)
 Table 30. Global Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Consumption by Region (Tons), 2021–2026
 Table 31. Global Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Consumption Market Share by Region (2021–2026)
 Table 32. Global Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Forecasted Consumption by Region (Tons), 2027–2032
 Table 33. Global Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Forecasted Consumption Market Share by Region (2027–2032)
 Table 34. North America Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Consumption Growth Rate by Country: 2021 vs 2025 vs 2032 (Tons)
 Table 35. North America Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Consumption by Country (Tons), 2021–2026
 Table 36. North America Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Consumption by Country (Tons), 2027–2032
 Table 37. Europe Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Consumption Growth Rate by Country: 2021 vs 2025 vs 2032 (Tons)
 Table 38. Europe Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Consumption by Country (Tons), 2021–2026
 Table 39. Europe Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Consumption by Country (Tons), 2027–2032
 Table 40. Asia Pacific Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Consumption Growth Rate by Region: 2021 vs 2025 vs 2032 (Tons)
 Table 41. Asia Pacific Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Consumption by Region (Tons), 2021–2026
 Table 42. Asia Pacific Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Consumption by Region (Tons), 2027–2032
 Table 43. Latin America, Middle East & Africa Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Consumption Growth Rate by Country: 2021 vs 2025 vs 2032 (Tons)
 Table 44. Latin America, Middle East & Africa Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Consumption by Country (Tons), 2021–2026
 Table 45. Latin America, Middle East & Africa Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Consumption by Country (Tons), 2027–2032
 Table 46. Global Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production (Tons) by Type (2021–2026)
 Table 47. Global Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production (Tons) by Type (2027–2032)
 Table 48. Global Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Market Share by Type (2021–2026)
 Table 49. Global Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Market Share by Type (2027–2032)
 Table 50. Global Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Value (US$ Million) by Type (2021–2026)
 Table 51. Global Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Value (US$ Million) by Type (2027–2032)
 Table 52. Global Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Value Market Share by Type (2021–2026)
 Table 53. Global Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Value Market Share by Type (2027–2032)
 Table 54. Global Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Price (US$/Ton) by Type (2021–2026)
 Table 55. Global Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Price (US$/Ton) by Type (2027–2032)
 Table 56. Global Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production (Tons) by Application (2021–2026)
 Table 57. Global Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production (Tons) by Application (2027–2032)
 Table 58. Global Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Market Share by Application (2021–2026)
 Table 59. Global Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Market Share by Application (2027–2032)
 Table 60. Global Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Value (US$ Million) by Application (2021–2026)
 Table 61. Global Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Value (US$ Million) by Application (2027–2032)
 Table 62. Global Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Value Market Share by Application (2021–2026)
 Table 63. Global Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Value Market Share by Application (2027–2032)
 Table 64. Global Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Price (US$/Ton) by Application (2021–2026)
 Table 65. Global Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Price (US$/Ton) by Application (2027–2032)
 Table 66. Herbalmax Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Company Information
 Table 67. Herbalmax Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Specification and Application
 Table 68. Herbalmax Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
 Table 69. Herbalmax Main Business and Markets Served
 Table 70. Herbalmax Recent Developments/Updates
 Table 71. Genex Formulas Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Company Information
 Table 72. Genex Formulas Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Specification and Application
 Table 73. Genex Formulas Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
 Table 74. Genex Formulas Main Business and Markets Served
 Table 75. Genex Formulas Recent Developments/Updates
 Table 76. Maac10 Formulas Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Company Information
 Table 77. Maac10 Formulas Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Specification and Application
 Table 78. Maac10 Formulas Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
 Table 79. Maac10 Formulas Main Business and Markets Served
 Table 80. Maac10 Formulas Recent Developments/Updates
 Table 81. GeneHarbor Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Company Information
 Table 82. GeneHarbor Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Specification and Application
 Table 83. GeneHarbor Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
 Table 84. GeneHarbor Main Business and Markets Served
 Table 85. GeneHarbor Recent Developments/Updates
 Table 86. Bontac Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Company Information
 Table 87. Bontac Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Specification and Application
 Table 88. Bontac Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
 Table 89. Bontac Main Business and Markets Served
 Table 90. Bontac Recent Developments/Updates
 Table 91. CELFULL Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Company Information
 Table 92. CELFULL Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Specification and Application
 Table 93. CELFULL Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
 Table 94. CELFULL Main Business and Markets Served
 Table 95. CELFULL Recent Developments/Updates
 Table 96. Zhongsheng Pharmaceutical Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Company Information
 Table 97. Zhongsheng Pharmaceutical Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Specification and Application
 Table 98. Zhongsheng Pharmaceutical Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
 Table 99. Zhongsheng Pharmaceutical Main Business and Markets Served
 Table 100. Zhongsheng Pharmaceutical Recent Developments/Updates
 Table 101. Mirailab Bioscience Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Company Information
 Table 102. Mirailab Bioscience Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Specification and Application
 Table 103. Mirailab Bioscience Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
 Table 104. Mirailab Bioscience Main Business and Markets Served
 Table 105. Mirailab Bioscience Recent Developments/Updates
 Table 106. EffePharm Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Company Information
 Table 107. EffePharm Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Specification and Application
 Table 108. EffePharm Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
 Table 109. EffePharm Main Business and Markets Served
 Table 110. EffePharm Recent Developments/Updates
 Table 111. Kingdomway Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Company Information
 Table 112. Kingdomway Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Specification and Application
 Table 113. Kingdomway Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
 Table 114. Kingdomway Main Business and Markets Served
 Table 115. Kingdomway Recent Developments/Updates
 Table 116. ‌Yaben Chemical‌ Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Company Information
 Table 117. ‌Yaben Chemical‌ Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Specification and Application
 Table 118. ‌Yaben Chemical‌ Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
 Table 119. ‌Yaben Chemical‌ Main Business and Markets Served
 Table 120. ‌Yaben Chemical‌ Recent Developments/Updates
 Table 121. Key Raw Materials Lists
 Table 122. Raw Materials Key Suppliers Lists
 Table 123. Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Distributors List
 Table 124. Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Customers List
 Table 125. Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Market Trends
 Table 126. Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Market Drivers
 Table 127. Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Market Challenges
 Table 128. Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Market Restraints
 Table 129. Research Programs/Design for This Report
 Table 130. Key Data Information from Secondary Sources
 Table 131. Key Data Information from Primary Sources
 Table 132. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide)
 Figure 2. Global Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Market Share by Type: 2025 vs 2032
 Figure 4. Purity ≥98% Product Picture
 Figure 5. Purity <98% Product Picture
 Figure 6. Global Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Market Value by Manufacturing Process (US$ Million), 2021–2032
 Figure 7. Global Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Market Share by Manufacturing Process: 2025 vs 2032
 Figure 8. Chemical Synthesis Product Picture
 Figure 9. Enzyme Catalysis Product Picture
 Figure 10. Fermentation Product Picture
 Figure 11. Global Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Market Value by Application (US$ Million), 2021–2032
 Figure 12. Global Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Market Share by Application: 2025 vs 2032
 Figure 13. Pharmaceuticals
 Figure 14. Health Products
 Figure 15. Others
 Figure 16. Global Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Value (US$ Million), 2021 vs 2025 vs 2032
 Figure 17. Global Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Value (US$ Million), 2021–2032
 Figure 18. Global Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Capacity (Tons), 2021–2032
 Figure 19. Global Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production (Tons), 2021–2032
 Figure 20. Global Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Average Price (US$/Ton), 2021–2032
 Figure 21. Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Report Years Considered
 Figure 22. Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Share by Manufacturers in 2025
 Figure 23. Global Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Value Share by Manufacturers (2025)
 Figure 24. Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 25. Top 5 and Top 10 Global Players: Market Share by Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Revenue in 2025
 Figure 26. Global Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Value by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Figure 27. Global Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Value Market Share by Region: 2021 vs 2025 vs 2032
 Figure 28. Global Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Comparison by Region: 2021 vs 2025 vs 2032 (Tons)
 Figure 29. Global Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Market Share by Region: 2021 vs 2025 vs 2032
 Figure 30. North America Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Value (US$ Million) Growth Rate (2021–2032)
 Figure 31. Europe Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Value (US$ Million) Growth Rate (2021–2032)
 Figure 32. China Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Value (US$ Million) Growth Rate (2021–2032)
 Figure 33. Japan Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Value (US$ Million) Growth Rate (2021–2032)
 Figure 34. India Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Value (US$ Million) Growth Rate (2021–2032)
 Figure 35. Southeast Asia Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Production Value (US$ Million) Growth Rate (2021–2032)
 Figure 36. Global Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Consumption by Region: 2021 vs 2025 vs 2032 (Tons)
 Figure 37. Global Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Consumption Market Share by Region: 2021 vs 2025 vs 2032
 Figure 38. North America Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Consumption and Growth Rate (Tons), 2021–2032
 Figure 39. North America Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Consumption Market Share by Country (2021–2032)
 Figure 40. U.S. Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Consumption and Growth Rate (Tons), 2021–2032
 Figure 41. Canada Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Consumption and Growth Rate (Tons), 2021–2032
 Figure 42. Europe Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Consumption and Growth Rate (Tons), 2021–2032
 Figure 43. Europe Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Consumption Market Share by Country (2021–2032)
 Figure 44. Germany Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Consumption and Growth Rate (Tons), 2021–2032
 Figure 45. France Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Consumption and Growth Rate (Tons), 2021–2032
 Figure 46. U.K. Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Consumption and Growth Rate (Tons), 2021–2032
 Figure 47. Italy Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Consumption and Growth Rate (Tons), 2021–2032
 Figure 48. Russia Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Consumption and Growth Rate (Tons), 2021–2032
 Figure 49. Asia Pacific Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Consumption and Growth Rate (Tons), 2021–2032
 Figure 50. Asia Pacific Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Consumption Market Share by Region (2021–2032)
 Figure 51. China Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Consumption and Growth Rate (Tons), 2021–2032
 Figure 52. Japan Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Consumption and Growth Rate (Tons), 2021–2032
 Figure 53. South Korea Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Consumption and Growth Rate (Tons), 2021–2032
 Figure 54. China Taiwan Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Consumption and Growth Rate (Tons), 2021–2032
 Figure 55. Southeast Asia Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Consumption and Growth Rate (Tons), 2021–2032
 Figure 56. India Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Consumption and Growth Rate (Tons), 2021–2032
 Figure 57. Latin America, Middle East & Africa Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Consumption and Growth Rate (Tons), 2021–2032
 Figure 58. Latin America, Middle East & Africa Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Consumption Market Share by Country (2021–2032)
 Figure 59. Mexico Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Consumption and Growth Rate (Tons), 2021–2032
 Figure 60. Brazil Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Consumption and Growth Rate (Tons), 2021–2032
 Figure 61. Turkey Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Consumption and Growth Rate (Tons), 2021–2032
 Figure 62. GCC Countries Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Consumption and Growth Rate (Tons), 2021–2032
 Figure 63. Global Production Market Share of Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) by Type (2021–2032)
 Figure 64. Global Production Value Market Share of Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) by Type (2021–2032)
 Figure 65. Global Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Price (US$/Ton) by Type (2021–2032)
 Figure 66. Global Production Market Share of Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) by Application (2021–2032)
 Figure 67. Global Production Value Market Share of Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) by Application (2021–2032)
 Figure 68. Global Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Price (US$/Ton) by Application (2021–2032)
 Figure 69. Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Value Chain
 Figure 70. Channels of Distribution (Direct Vs Distribution)
 Figure 71. Bottom-up and Top-down Approaches for This Report
 Figure 72. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Leap India

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions